KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bionano Genomics (BNGO) Leases (2021 - 2025)

Bionano Genomics (BNGO) has disclosed Leases for 5 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Leases rose 78.33% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, up 78.33% year-over-year, with the annual reading at $3.2 million for FY2025, 78.33% up from the prior year.
  • Leases hit $3.2 million in Q4 2025 for Bionano Genomics, down from $3.5 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $6.8 million in Q1 2022 to a low of $1.8 million in Q4 2024.
  • Historically, Leases has averaged $4.1 million across 5 years, with a median of $3.6 million in 2023.
  • Biggest five-year swings in Leases: tumbled 49.2% in 2024 and later skyrocketed 78.33% in 2025.
  • Year by year, Leases stood at $3.9 million in 2021, then fell by 5.58% to $3.7 million in 2022, then dropped by 5.5% to $3.5 million in 2023, then crashed by 48.5% to $1.8 million in 2024, then surged by 78.33% to $3.2 million in 2025.
  • Business Quant data shows Leases for BNGO at $3.2 million in Q4 2025, $3.5 million in Q3 2025, and $3.8 million in Q2 2025.